Abstract
Small bowel adenocarcinoma is a rare disease occurring 50–100-fold less often than colorectal cancer. This commentary describes similarities and differences between the two diseases and related results of recent clinical trials.
Cite
CITATION STYLE
APA
Safyan, R. A., & Neugut, A. I. (2018). Anti-EGFR Therapy in Small Bowel Adenocarcinoma. The Oncologist, 23(3), 275–276. https://doi.org/10.1634/theoncologist.2017-0688
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free